Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PUMA BIOTECHNOLOGY, INC. Director's Dealing 2021

Jul 16, 2021

33488_dirs_2021-07-16_6392c71a-edb4-44f3-a41a-6f352d1a585d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2021-07-15

Reporting Person: Dorval Allison (Director)